Literature DB >> 20662322

Inhibitory activity of ginsenosides isolated from processed ginseng on platelet aggregation.

Jin Gyun Lee1, Yong Yook Lee, Bo Wu, Sun Young Kim, Yong Jae Lee, Hye Sook Yun-Choi, Jeong Hill Park.   

Abstract

Seven ginsenosides, namely Rg6 (1), F4 (2), Rk3 (3), Rh4 (4), Rs3 (5), Rs4 (6) and Rs5 (7) isolated from processed ginseng were evaluated for their effects on platelet aggregation induced by adenosine diphosphate (ADP), collagen, arachidonic acid (AA) and U46619 (thromboxane A2 mimetic drug). Ginsenosides Rg6, F4 and Rk3 showed inhibitory activity (IC50 = 76 microM, 114 microM and 128 microM, respectively) on AA-induced platelet aggregation. The corresponding IC50 values were comparable to that of acetylsalicylic acid (ASA) (63 microM). Compared to ASA (IC50 = 468 microM) ginsenosides Rg6, F4, Rk3 and Rh4 were found to be more inhibitive (IC50 = 286 microM, 87 microM, 187 microM and 119 microM, respectively) against U46619-induced aggregation. On the other hand, most of the ginsenosides (Rg6, F4, Rh4, Rs3, Rs5) showed negligible effects on ADP and collagen-induced platelet aggregation. The acetylated ginsenosides (Rs3, Rs4 and Rs5) had only mild effects on aggregation induced by four stimulators.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20662322

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  8 in total

Review 1.  Metabolism of ginseng and its interactions with drugs.

Authors:  Lian-Wen Qi; Chong-Zhi Wang; Guang-Jian Du; Zhi-Yu Zhang; Tyler Calway; Chun-Su Yuan
Journal:  Curr Drug Metab       Date:  2011-11       Impact factor: 3.731

2.  Ginsenoside Rb3 attenuates oxidative stress and preserves endothelial function in renal arteries from hypertensive rats.

Authors:  Youhua Wang; Jinghui Dong; Ping Liu; Chi Wai Lau; Zhen Gao; Duan Zhou; Jingyi Tang; Chi Fai Ng; Yu Huang
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

Review 3.  A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases.

Authors:  Chang Ho Lee; Jong-Hoon Kim
Journal:  J Ginseng Res       Date:  2014-04-03       Impact factor: 6.060

4.  Studies of the effects and mechanisms of ginsenoside Re and Rk3 on myelosuppression induced by cyclophosphamide.

Authors:  Jiahong Han; Jing Xia; Lianxue Zhang; Enbo Cai; Yan Zhao; Xuan Fei; Xiaohuan Jia; He Yang; Shuangli Liu
Journal:  J Ginseng Res       Date:  2018-08-30       Impact factor: 6.060

5.  The construction of the novel magnetic prodrug Fe3O4@DOX and its antagonistic effects on hepatocarcinoma with low toxicity.

Authors:  Jun Li; Liang Li; Yang Lv; Hao Zou; Yanping Wei; Fei Nie; Wanli Duan; Maidinamu Sedike; Liang Xiao; Mei Wang
Journal:  RSC Adv       Date:  2020-08-05       Impact factor: 4.036

6.  Cardiovascular Diseases and Panax ginseng: A Review on Molecular Mechanisms and Medical Applications.

Authors:  Jong-Hoon Kim
Journal:  J Ginseng Res       Date:  2012-01       Impact factor: 6.060

7.  Ginsenoside RK3 Prevents Hypoxia-Reoxygenation Induced Apoptosis in H9c2 Cardiomyocytes via AKT and MAPK Pathway.

Authors:  Jing Sun; Guibo Sun; Xiangbao Meng; Hongwei Wang; Min Wang; Meng Qin; Bo Ma; Yun Luo; Yingli Yu; Rongchang Chen; Qidi Ai; Xiaobo Sun
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-27       Impact factor: 2.629

Review 8.  Anti-platelet role of Korean ginseng and ginsenosides in cardiovascular diseases.

Authors:  Muhammad Irfan; Minki Kim; Man Hee Rhee
Journal:  J Ginseng Res       Date:  2019-05-21       Impact factor: 6.060

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.